Age

45–75

Sex

MALE

Healthy volunteers

Not accepted

Signature of informed consent prior to performing any of the specific procedures of the study
Age between 50 \* - 75 years (\* 45 years, if family history)
Patients with clinical suspicion of prostate cancer
Indication of a first biopsy during the study period.
Life expectancy greater than 10 years.

Patients previously randomized in the present study.
Patients submitted prior to a prostate biopsy.
Patients with a previous diagnosis of prostate cancer and / or previous prostate surgery.
Patients with a previous episode of acute prostatitis of infectious origin in the 3 months prior to inclusion in the study.
Patients with an active urinary tract infection and / or any previous pathology of severity in the 3 months prior to inclusion.
Impossibility of performing transrectal or transperineal biopsy and / or magnetic resonance.
Patients who have received hormonal treatment prior to androgen blockade in the 6 months prior to inclusion in the study.
History of other tumors.

Impact of Magnetic Resonance and Biomarkers for Screening for Prostate Cancer. Cost-effectiveness Analysis